Veradigm | Ventes



Sales Changement Date
Alcidion AUD 17.64M 8.64M 2024-12
Ambu A/S DKK 1.55B 40M 2025-03
Amplifon EUR 587.9M 76.3M 2025-03
Cardinal Health USD 54.9B 364M 2025-03
Centene USD 46.62B 5.82B 2025-03
Charles River Laboratories USD 984.2M 18.35M 2025-03
Cigna USD 65.5B 149M 2025-03
Convatec Group 1.18B 70M 2024-12
CVS Health USD 94.6B 3.11B 2025-03
Diasorin EUR 313M 4M 2025-03
Elevance Health 48.8B 3.8B 2025-03
General Electric USD 9.94B 60M 2025-03
Gulf Medical Proj AED 180.05M 8.28M 2025-03
Humana USD 32.11B 2.91B 2025-03
IQVIA Holdings USD 3.83B 128M 2025-03
Kora Saude BRL 556.45M 7.62M 2024-12
Laboratory Of America USD 3.35B 20.6M 2025-03
Maximus USD 1.36B 42.68M 2025-03
McKesson USD 90.82B 4.47B 2025-03
Med Life RON 736.79M 68.5M 2024-12
Molina Healthcare USD 11.15B 650M 2025-03
Omnicell USD 269.67M 37.21M 2025-03
Oriola-kd EUR 440.7M 16.3M 2024-12
Owens Minor USD 2.63B 66.07M 2025-03
Quest Diagnostics USD 2.65B 30M 2025-03
Rede D'or Sao Luiz BRL 13.68B 520M 2025-03
Siemens Healthineers EUR 5.91B 430M 2025-03
Sonova Holding CHF 1.83B 40.7M 2024-09
Supermax Corporation Bhd MYR 198.79M 19.15M 2024-12
UnitedHealth 109.6B 8.79B 2025-03
Veeva Systems USD 759M 38.11M 2025-04
Walgreens Boots Alliance USD 39B 400M 2025-05
Xerox USD 1.46B 153M 2025-03



Veradigm Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.